COMMUNIQUÉS West-GlobeNewswire

Invivoscribe Submits the LeukoStrat CDx FLT3 Mutation Assay to Support Daiichi Sankyo Submission for Quizartinib in Japan
19/11/2018
SAN DIEGO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- In support of an ongoing partnership with Daiichi Sankyo, Invivoscribe is pleased to announce submission of the LeukoStrat ® CDx FLT3 Mutation Assay to the PMDA ( [...]
Minerva Neurosciences Announces Results of Dose Escalation Study Evaluating Roluperidone (MIN-101) Administered at Supra-Therapeutic Doses in Healthy Volunteers
19/11/2018
Findings suggest expanded therapeutic window and significantly improved cardiovascular safety margin compared to formulation used in Phase 2b trial All doses tested up to 256 milligrams appear safe and well tolerated [...]
Ceapro Inc. Announces Completion of Successful Audits by Major Customers
19/11/2018
- New Edmonton-based facility fully commissioned and first orders shipped - Filed for a Drug Establishment License from Health Canada to allow the Company to handle biopharmaceuticals products EDMONTON, Alberta, Nov. 19 [...]
BrainStorm Cell Therapeutics Announces Submission of IND for NurOwn® in Progressive Multiple Sclerosis
19/11/2018
NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases, today [...]
Concierge Care Samaritans Makes Monetary Donation to the Federal Way Senior Center
19/11/2018
SEATTLE, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Concierge Care Advisors , Washington’s premier senior living and care resource agency, today announced its Concierge Care Samaritans have provided a monetary donation of $1,000 [...]
Samumed Doses First Subject in Phase 2/3 Trial of SM04554 for the Treatment of Androgenetic Alopecia
19/11/2018
Top-line Data Expected in Second Half of 2020 SAN DIEGO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has dosed the first subject in its phase 2/3 trial of SM04554, a topical small molecule [...]
Aura Announces Appointment of New Chief Operating Officer and Board Approval of Stock-Based Compensation Plan
19/11/2018
TORONTO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Aura Health Inc. (the " Company " or “ Aura ”) ( CSE:BUZZ ) is pleased to announce the appointment of Howard Brass to the role of Chief Operating Officer, effective immediately [...]
Milestone Scientific Schedules Third Quarter 2018 Conference Call
19/11/2018
LIVINGSTON, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced [...]
Aeterna Zentaris (AEZS) Receives Positive CHMP Opinion of Macimorelin for Diagnosis of Adult Growth Hormone Deficiency
19/11/2018
CHARLESTON, S.C., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS), announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted [...]
AgPlenus, a subsidiary of Evogene, to Present at the 2nd Annual AgChem & Technology Europe Conference
19/11/2018
Boaz Inbal, VP R&D, will present AgPlenus' unique approach for biology-driven discovery and introduce AgPlenus' vision and pipeline REHOVOT, Israel, Nov. 19, 2018 (GLOBE NEWSWIRE) -- AgPlenus, a fully owned [...]
First Choice Healthcare Solutions Appoints Phillip Keller as Interim CEO
19/11/2018
The Independent Board of Directors Announce Additional Updates MELBOURNE, Fla., Nov. 19, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("First Choice" or the "Company"), a fully [...]
Fortress Biotech Announces Agreement to Sell Its Majority Stake in National Holdings Corporation to NHC Holdings, LLC, a wholly-owned subsidiary of B. Riley Financial
19/11/2018
NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]
Management Changes at Rafina Innovations Inc.
19/11/2018
Glasgow, Scotland, Nov. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Rafina Innovations Inc. (formerly HCi Viocare) (OTCQB:VICA) , provides update on recent management changes. Rafina Innovations Inc. was created to [...]
Marinus Pharmaceuticals to Present Ganaxolone Clinical Trial Data in CDKL5 Deficiency Disorder and PCDH19-Related Epilepsy at AES
19/11/2018
RADNOR, Pa., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]
Radient Technologies Inc. Files Provisional Patent Applications for Innovating Cannabis Supply Chain and Expands Operational Capabilities in Europe
19/11/2018
EDMONTON, Alberta, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ) is pleased to announce that it has now filed an additional 13 provisional patent [...]
CHMP Issues Positive Opinion on Split Dosing Regimen for DARZALEX® (daratumumab)
19/11/2018
Media Release CHMP issued positive opinion on split dosing regimen for DARZALEX Final decision from European Commission expected in the coming months Opinion supported by data from EQUULEUS (MMY1001) clinical trial [...]
Myriad Announces $50 Million Accelerated Share Repurchase Program
19/11/2018
SALT LAKE CITY, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that the company has entered into an accelerated share repurchase (“ASR [...]
Sunesis Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference
19/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President, Finance and Corporate [...]
Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech
19/11/2018
PRESS RELEASE Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech First-in-human clinical trial of IMC-C103C scheduled to commence in 2019 in multiple solid tumour indications ( [...]

Pages